Sucralfate

硫糖铝

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSucralfate
Drug Alias NameSucralfatum胃溃宁sucralfato蔗糖硫酸酯铝硫糖药 +[14] 
ClassificationSmall molecules > Carbohydrate
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsFissure in AnoStomach UlcerDuodenal Ulcer +[4] 
Global Approved IndicationsStomach UlcerDuodenal UlcerGastritis
Approved Indications in ChinaStomach UlcerDuodenal UlcerGastritis
Original Approved Country/TerritoryMainland China
Original Approved Date1981/01/01
Country/TerritoryUnited StatesEgyptMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAllergan Plc
China Registration ClassN/A

Develop Information

Active CompaniesSuez Canal UniversityAbbvie IncSinopharm Wuhan Zhonglian Siyao Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsFissure in AnoStomach UlcerDuodenal Ulcer +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeA02BX02
Related LinksWikipediaDrugBankKEGG